Company Filing History:
4 out of 1,975 
1 out of 152 
Years Active: 2009-2012
Title: The Innovations of James J S Treanor
Introduction
James J S Treanor is a notable inventor based in Sherman Oaks, CA. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of 4 patents to his name, Treanor's work has the potential to impact the treatment of various medical conditions.
Latest Patents
One of Treanor's latest patents is focused on human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors. This invention provides antibodies that interact with or bind to human nerve growth factor (NGF) and neutralize its function. The invention also includes pharmaceutical compositions of these antibodies and methods for neutralizing NGF function. This is particularly relevant for treating NGF-related disorders, such as chronic pain, by administering a pharmaceutically effective amount of anti-NGF antibodies. Additionally, methods for detecting the amount of NGF in a sample using anti-NGF antibodies are also provided.
Career Highlights
Throughout his career, Treanor has worked with prominent companies in the biotechnology sector, including Amgen Inc. and Medarex Inc. His experience in these organizations has contributed to his expertise in developing innovative solutions in the field of medical science.
Collaborations
Some of Treanor's notable coworkers include Kenneth D Wild, Jr. and Haichun Huang. Their collaborative efforts have likely played a role in advancing the research and development of therapeutic antibodies.
Conclusion
James J S Treanor's contributions to the field of biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of chronic pain and other NGF-related disorders.